Brand Name(s): Exelon
CAS nº: 123441-03-2
(ri va STIG meen)
What is Rivastigmine?
Rivastigmine improves the function of nerve cells in the brain, and works by preventing the breakdown of a chemical called acetylcholine. People with dementia usually have lower levels of this chemical, which is important for the processes of memory, thinking, and reasoning.
Rivastigmine is approved for mild to moderate dementia of the Alzheimer’s type and for mild to moderate dementia related to Parkinson’s disease.
It is sold in the US under that trade name Exelon® but is also known as Prometax® in the UK. It was previously known as SDZ ENA 713.
Latest News
Dr. Reddy's Announces Settlement of Exelon (rivastigmine tartrate) ANDA Litigation With Novartis
Dr. Reddy's Laboratories (NYSE:RDY) today announced that it has entered into a settlement agreement...
[more]Novartis Exelon patch gets EU nod for Alzheimer's
The European Union has approved Novartis's Exelon skin patch to treat Alzheimer's disease, the...
[more]First and only skin patch for mild to moderate Alzheimer's disease is approved in the U.S.
For the first time, people suffering from mild to moderate Alzheimer's disease have a transdermal...
[more]SCOLR Announces Completion of 12 hour CDT-Pseudoephedrine ANDA Registration Batches, New Drug Development Targets
SCOLR Pharma, Inc. (Amex: DDD) announced today that its contract manufacturing partner, Cardinal...
[more]Few Alzheimer's treatments now and no cure ... yet
When a person is diagnosed with Alzheimer’s disease, the prognosis is not a good one.
[more]